A carregar...
Projeto de investigação
Antimicrobial resistance in staphylococci causing skin and soft-tissues infections
Financiador
Autores
Publicações
Virulence potential of biofilm-producing Staphylococcus pseudintermedius, Staphylococcus aureus and Staphylococcus coagulans causing skin infections in companion animals
Publication . Andrade, Mariana; Oliveira, Ketlyn; Morais, Catarina; Abrantes, Patrícia; Pomba, C.; Rosato, Adriana E.; Couto, Isabel; Costa, Sofia Santos
ABSTRACT . Coagulase-positive staphylococci (CoPS) account for most bacteria-related pyoderma in
companion animals. Emergence of methicillin-resistant strains of Staphylococcus pseudintermedius
(MRSP), Staphylococcus aureus (MRSA) or Staphylococcus coagulans (MRSC), often with multidrugresistant (MDR) phenotypes, is a public health concern. The study collection comprised 237 staphylococci (S. pseudintermedius (n = 155), S. aureus (n = 55) and S. coagulans (n = 27)) collected from companion animals, previously characterized regarding resistance patterns and clonal lineages. Biofilm production was detected for 51.0% (79/155), 94.6% (52/55) and 88.9% (24/27) of the
S. pseudintermedius, S. aureus and S. coagulans, respectively, and was a frequent trait of the predominant S. pseudintermedius and S. aureus clonal lineages. The production of biofilm varied with
NaCl supplementation of the growth media. All S. pseudintermedius and S. aureus strains carried
icaADB. Kaplan–Meier survival analysis of Galleria mellonella infected with different CoPS revealed a
higher virulence potential of S. aureus when compared with other CoPS. Our study highlights a high
frequency of biofilm production by prevalent antimicrobial-resistant clonal lineages of CoPS associated with animal pyoderma, potentially related with a higher virulence potential and persistent or
recurrent infections.
Unidades organizacionais
Descrição
Palavras-chave
Contribuidores
Financiadores
Entidade financiadora
Fundação para a Ciência e a Tecnologia
Programa de financiamento
Número da atribuição
UI/BD/151061/2021
